HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- We are not alone, and are seeing more RED
- Huntington Study Group (HSG) Conference 2024 – Day 3
- Huntington Study Group (HSG) Conference 2024 – Day 2
- Huntington Study Group (HSG) Conference 2024 – Day 1
- 2024 HDBuzz Prize: Social Skills - The Hidden Gem in Improving Quality of Life for People with Huntington's disease?
Literature
- Apathy and Functional Status in Early-Stage Huntington's Disease
- Preventing acute neurotoxicity of CNS therapeutic oligonucleotides with the addition of Ca<sup>2+</sup> and Mg<sup>2+</sup> in the formulation
- Nanopore Identification of Polyglutamine Length via Cross-Slit Sensing
- A special focus on polyadenylation and alternative polyadenylation in neurodegenerative diseases: A systematic review
- Mitochondrial DAMPs: Key Mediators in Neuroinflammation and Neurodegenerative Disease Pathogenesis
News
- Cardiovascular Researchers Dramatically Reduce Size and Severity of Stroke Using ... - BioSpace
- Driving Innovation in Aging and Neurodegenerative Research: Henri Ford, MD, MHA
- Synapticure scores $25M to scale platform for neurodegenerative diseases
- Dalzanemdor fails to meet endpoints in phase 2 study of patients with Huntington's disease
- The dust has settled: Sage's dalzanemdor won't advance for cognitive impairment - HDBuzz